Considerations in biomarker development for neurodevelopmental disorders
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Despite significant progress in recognizing the biological bases of autism spectrum disorder, diagnosis and treatment rely primarily on subjective evaluation of behavior. This review highlights the challenges unique to neurodevelopmental disorders that have limited biomarker development. RECENT FINDINGS: The field of neurodevelopmental disorders requires objective quantification of biological processes to enable designation of subgroups likely to benefit from specific treatments, index diagnostic status/risk, demonstrate engagement of targeted systems, and provide more rapid assessment of change than traditional clinical observation and caregiver report measures. SUMMARY: Useful biomarkers for neurodevelopmental disorders must be reliable across development, evident at the individual level, and specific to a unit of analysis, be it diagnostic status or functional process. The ultimate value of biomarkers for neurodevelopmental disorders will relate to their ease of use, cost, scalability, sensitivity, and methodological objectivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Die „Autistischen Psychopathen” im Kindesalter
Asperger, H. (1944) · Archiv für Psychiatrie und Nervenkrankheiten · doi:10.1007/bf01837709 · Cited by 2,163
INFANTILE AUTISM: A GENETIC STUDY OF 21 TWIN PAIRS
Folstein, S., & Rutter, M. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00443.x · Cited by 1,361 · cited 1×
“Years later, pioneering genetic studies demonstrated the role of heritability by documenting higher concordance rates among monozygotic twins [2].”
BackgroundDawson, G., Webb, S. J., & McPartland, J. (2005) · Developmental Neuropsychology · doi:10.1207/s15326942dn2703_6 · Cited by 989
Self-citationHistoanatomic observations of the brain in early infantile autism
Bauman, M., & Kemper, T. L. (1985) · Neurology · doi:10.1212/wnl.35.6.866 · Cited by 964
Dawson, G., Jones, E. J. H., Merkle, K., Venema, K., Lowy, R., Faja, S., Kamara, D., Murias, M., Greenson, J., Winter, J., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.018 · Cited by 799
Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development
Bernier, R., Golzio, C., Xiong, B., Stessman, H. A., Coe, B. P., Penn, O., Witherspoon, K., Gerdts, J., Baker, C., Vulto-van Silfhout, A. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.017 · Cited by 798
Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder
McPartland, J. C., Reichow, B., & Volkmar, F. R. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.007 · Cited by 476
Self-citationIn search of biomarkers for autism: scientific, social and ethical challenges
Walsh, P., Elsabbagh, M., Bolton, P., & Singh, I. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3113 · Cited by 249
Moving beyond a categorical diagnosis of autism
Volkmar, F. R., & McPartland, J. C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00299-9 · Cited by 19 · cited 1×
“Given environmental interactions with genotype and developmental experience, in all but a subset of cases [14 && ] it may be difficult to extrapolate diagnostic status or developmental course based on genetic markers, suggesting the potential import of intermediary quantifications of the phenotype, such as measures of…”
BackgroundSelf-citation
Cited by
Loth, E., Charman, T., Mason, L., Tillmann, J., Jones, E. J. H., Wooldridge, C., Ahmad, J., Auyeung, B., Brogna, C., Ambrosino, S., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0146-8 · Cited by 299
Veenstra-VanderWeele, J., Cook, E. H., King, B. H., Zarevics, P., Cherubini, M., Walton-Bowen, K., Bear, M. F., Wang, P. P., & Carpenter, R. L. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.237 · Cited by 168
Atypicality of the N170 Event-Related Potential in Autism Spectrum Disorder: A Meta-analysis
Kang, E., Keifer, C. M., Levy, E. J., Foss-Feig, J. H., McPartland, J. C., & Lerner, M. D. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.11.003 · Cited by 144
Self-citationThe meaning of significant mean group differences for biomarker discovery
Loth, E., Ahmad, J., Chatham, C., López, B., Carter, B., Crawley, D., Oakley, B., Hayward, H., Cooke, J., San José Cáceres, A., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009477 · Cited by 52
Foss-Feig, J. H., Stavropoulos, K. K. M., McPartland, J. C., Wallace, M. T., Stone, W. L., & Key, A. P. (2018) · Developmental Neuropsychology · doi:10.1080/87565641.2017.1365869 · Cited by 16
“In his summary of considerations for biomarker development for neurodevelopmental disorders, McPartland (2016) highlighted the need for measures that were relatively easy to use across the full ASD spectrum, inexpensive and scalable, sensitive to subtle changes, and objective in their methodology.”
BackgroundSelf-citation
Metadata
- Authors
- McPartland, J. C.
- Venue
- Current Opinion in Neurology
- Published
- 2016-04
- Volume
- 29
- Issue
- 2
- Pages
- 118-122
- ISSN
- 1350-7540 (ISSN-L)
- OpenAlex
- W2315339043
- Cited by
- 80
- References
- 9
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Considerations in biomarker development for neurodevelopmental disorders. https://app.cochat.ai/papers/10.1097/wco.0000000000000300
- The paper
- McPartland, J. C. (2016). Considerations in biomarker development for neurodevelopmental disorders. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.